National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,253 cases where Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis

Government Disclaimer on use of this data



Case Details

This is page 29 out of 2,126

Result pages: prev   20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38   next


VAERS ID: 1039020 (history)  
Form: Version 2.0  
Age: 29.0  
Sex: Female  
Location: South Carolina  
Vaccinated:2021-02-01
Onset:2021-02-15
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Petechiae, Rash, Rash erythematous
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vyvanse 20 mg, cymbalta and Wellbutrin
Current Illness: N/a
Preexisting Conditions: No
Allergies: N/a
Diagnostic Lab Data: N/a
CDC Split Type:

Write-up: Red spots/rash on left arm, hand, and wrist. Petechia rash.


VAERS ID: 1039940 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: California  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021130304

Write-up: Blood clot in her leg; This is a spontaneous report from a non-contactable consumer (patient). This female patient of unspecified age (reported only as 72) received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date, for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient believed she may have a blood clot in her leg since an unspecified date. She had the second vaccine dose scheduled on an unknown date. Event outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.


VAERS ID: 1039944 (history)  
Form: Version 2.0  
Age: 88.0  
Sex: Female  
Location: Kansas  
Vaccinated:2021-02-04
Onset:2021-02-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Senior Living       Purchased by: ?
Symptoms: Haemoglobin, Haemoglobin decreased, Immune thrombocytopenia
SMQs:, Haematopoietic erythropenia (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Systemic lupus erythematosus (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Blood pressure high; Diabetes
Allergies:
Diagnostic Lab Data: Test Date: 20210204; Test Name: hemoglobin; Result Unstructured Data: Test Result:Drop
CDC Split Type: USPFIZER INC2021142503

Write-up: Drop in hemoglobin level; Idiopathic thrombocytopenic purpura; This is a spontaneous report from a contactable consumer. An 88-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration, on 04Feb2021, at single dose, for COVID-19 immunisation. Medical history included diabetes mellitus, hypertension and other unspecified conditions. Patient did not have known allergies and did not have COVID-19 prior to vaccination. Concomitant included unspecified multiple medications. Previously the patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech) for COVID-19 immunisation. The patient did not receive other vaccine in four weeks. The patient experienced drop in hemoglobin level resulting in idiopathic thrombocytopenic purpura (ITP) on 04Feb2021 with outcome of not recovered. The event resulted in physician office visit and emergency room visit. Patient had no history of ITP prior to vaccination. The event was considered serious as caused patient''s hospitalization and as life threatening. The patient underwent lab tests and procedures which included hemoglobin: drop on 04Feb2021. Therapeutic measures were taken as a result of the event and included treatment with multiple unspecified drugs. It was unknown if she was tested for COVID-19 after vaccination. The information on the lot/batch number has been requested.


VAERS ID: 1040183 (history)  
Form: Version 2.0  
Age: 94.0  
Sex: Female  
Location: Ohio  
Vaccinated:2021-01-29
Onset:2021-01-29
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 UN / -

Administered by: Unknown       Purchased by: ?
Symptoms: Coronary artery disease, Death, Myocardial infarction, Swelling face
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Other ischaemic heart disease (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-04
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 6 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: CHF
Preexisting Conditions: CHF, Diabetes
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient had swelling around her jaw after her second shot of the covid , Pfizer vaccine ( .5 ml IM) on the Friday morning, January 29th, I took her to a follow up appointment with the cardiologist at 3:00 pm, as a follow up to a small heart attack event with hospitalization two weeks previously, at the cardiologist she was given the ok/all is well. That next morning early, she had a 911 event at her assisted living apartment and was sent back to the hospital, having had another heart attack. Patient died on the following Thursday, February 4, 2021. I do not know if the vaccination had any cause for my mothers death; but I feel it is necessary to report this series of heart attacks after she received the pfizer vaccine. Her Certificate of Death records the cause of death as "Coronary Artery Disease".


VAERS ID: 1040290 (history)  
Form: Version 2.0  
Age: 80.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-02-08
Onset:2021-02-15
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-02-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Haemoglobin normal, Platelet count increased, Thrombocytopenia, White blood cell count normal
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tramadol, diazepam, finasteride, pancrelipase, allopurinol, hydrochlorothiazide, ezetimibe, Lupron, rivaroxaban, insulin
Current Illness: Prostate cancer, urethral polyp biopsy on 2/4/21.
Preexisting Conditions: Prostate cancer (localized) HTN Diabetes DVT and prothrombin gene mutation, but last clot in 2013 CAD
Allergies: Pravastatin
Diagnostic Lab Data: CBC revealing low platelet count, WBC and hgb normal.
CDC Split Type:

Write-up: Severe thrombocytopenia with platelet count of 1,000.


VAERS ID: 1040552 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2021-01-05
Onset:2021-02-02
   Days after vaccination:28
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Abdominal pain, Haemorrhage, Thrombosis
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CONCERTA; METHENAMINE; MIRENA; PROPRANOL; VITAMIN C [ASCORBIC ACID]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Fruit allergy; Idiopathic hypersomnia
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021117335

Write-up: experienced crippling lower abdominal pain followed by very very heavy bleeding and clotting; experienced crippling lower abdominal pain followed by very very heavy bleeding and clotting; experienced crippling lower abdominal pain followed by very very heavy bleeding and clotting; This is a spontaneous report from a contactable healthcare professional (patient). A 32-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration in the left arm on 05Jan2021 10:15 at a single dose for COVID-19 immunization at a hospital. Medical history included idiopathic hypersomnia and allergies to eggplant. The patient has no covid prior to vaccination. Concomitant medications included methylphenidate hydrochloride (CONCERTA), methenamine, levonorgestrel (MIRENA), propranolol hydrochloride (PROPRANOL) and vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]). The patient had no other vaccine in four weeks. The patient previously took cefazolin and levaquin and experienced allergies to both. The patient has a Mirena IUD and never get her period at all. Within 6 hours of her first Pfizer injection (02Feb2021 16:00), the patient experienced crippling lower abdominal pain followed by very very heavy bleeding and clotting. Resolved within 48 hours as quickly as it came and didn''t occur with second dose 1 week out. The patient was not tested for Covid post vaccination. The events were not treated. The outcome of the events was recovered on 04Feb2021. Information on the lot/batch number has been requested.; Sender''s Comments: Based on available information and known drug profile it is unlikely that the reported events were causally related to BNT162B2. These are intercurrent conditions. A contributory role of the patient''s Mirena IUD should be evaluated. Case will be reassessed if additional information is received. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 1040874 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-01-30
Onset:2021-02-06
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN9581 / 1 RA / IM

Administered by: School       Purchased by: ?
Symptoms: Chest discomfort, Computerised tomogram thorax, Deep vein thrombosis, Dizziness, Dyspnoea exertional, Echocardiogram, Pulmonary embolism, Scan with contrast, Tachycardia, Ultrasound Doppler, Ultrasound Doppler abnormal, Ultrasound scan
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Vestibular disorders (broad), Dehydration (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Cardizem, zoloft, Lipitor, Baby aspirin
Current Illness: Hypertension, High Cholersterol
Preexisting Conditions: Chronic back pain. Previous back surgeries. Had provoked blood clot after back surgery in 2004
Allergies: None
Diagnostic Lab Data: Unsure of all lab results at present time. CT scan with contrast of chest on 1/17/2021. Echo and US of legs on 1/18/2021. US of carotid arteries on 1/19/21
CDC Split Type:

Write-up: Within one week of receiving vaccine, experienced shortness of breath and chest tightness on exertion, lightheadedness, tachycardia. Became increasing worse over next 5 days. Visit to ER on 1/18/21. Diagnosed with many bilateral pulmonary emboli with clots in both pulmonary arteries. Admitted to hospital and started on Eliquis. Had doppler on legs which showed DVT.


VAERS ID: 1040968 (history)  
Form: Version 2.0  
Age: 39.0  
Sex: Female  
Location: South Carolina  
Vaccinated:2021-01-13
Onset:2021-01-18
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ1685 / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Abdominal pain, Alanine aminotransferase increased, Antimitochondrial antibody normal, Antineutrophil cytoplasmic antibody, Antinuclear antibody, Aspartate aminotransferase increased, Autoantibody negative, Bilirubin conjugated increased, Biopsy liver abnormal, Blood alkaline phosphatase increased, Blood bilirubin increased, Blood immunoglobulin M, Chills, Cholelithiasis, Colitis ulcerative, Computerised tomogram abnormal, Cytomegalovirus test, Decreased appetite, Diarrhoea, Epistaxis, Epstein-Barr virus test, Gastric varices, Hepatic cirrhosis, Hepatic enzyme abnormal, Hepatitis A antibody, Hepatitis B core antibody negative, Hepatitis B surface antibody positive, Hepatitis B surface antigen negative, Hepatitis C antibody negative, Hepatomegaly, Hyperhidrosis, Jaundice, Lip haemorrhage, Magnetic resonance imaging abdominal abnormal, Microcytic anaemia, Monocyte count increased, Monocytosis, Non-alcoholic steatohepatitis, Occupational exposure to SARS-CoV-2, Ocular icterus, Petechiae, Platelet count decreased, Portal hypertension, Portal hypertensive gastropathy, Proctitis, Prurigo, Rash, Rash maculo-papular, SARS-CoV-2 test negative, Smooth muscle antibody negative, Splenic varices, Splenomegaly, Thrombocytopenia, Ultrasound scan abnormal
SMQs:, Liver related investigations, signs and symptoms (narrow), Cholestasis and jaundice of hepatic origin (narrow), Hepatitis, non-infectious (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Liver infections (narrow), Anaphylactic reaction (broad), Acute pancreatitis (narrow), Haematopoietic erythropenia (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal ulceration (narrow), Biliary system related investigations, signs and symptoms (narrow), Gallbladder related disorders (narrow), Biliary tract disorders (narrow), Gallstone related disorders (narrow), Gastrointestinal nonspecific inflammation (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Cardiomyopathy (broad), Conjunctival disorders (narrow), Hypersensitivity (narrow), Noninfectious diarrhoea (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Claritin 10 mg Daily Melatonin 5 mg Nightly Multivitamin Daily Ritalin 20 mg 4 times Daily
Current Illness: None reported
Preexisting Conditions: Anxiety, Asthma, Polycystic ovarian syndrome, Depression
Allergies: Codeine
Diagnostic Lab Data: Included in summary of events
CDC Split Type:

Write-up: The patient was admitted to the hospital on February 10, 2021 for evaluation of jaundice. This is a healthcare worker (direct patient care) and she received the first dose of Covid 19 vaccine in January 13 2021, then subsequently developed some abnormalities of the liver enzymes and thrombocytopenia. Because of this, her second vaccine was held. She also subsequently noticed scleral jaundice. She reports that it was 5 days since the COVID-19 vaccine on January 13 when she developed a rash which was present in the legs anterior abdomen and arms. Then 8 days after the vaccine, she developed a different rash on top of the original which was less petechial and more maculopapular. The rash is pruriginous, its been intermittently worsening and improving. She had no fever associated with the rash, although she reports that the day before admission February 9, she had some chills and sweats. She had some mild abdominal pain and cramps. No prior history of hepatitis. She also developed a petechial rash predominantly in the lower extremities. Results of ancillary studies showed that her AST is currently (02/12/21) 196 ALT of 61, her bilirubin total was 7.9 with a direct of 5.5, and on admission her AST was 183 ALT 40, with a total bilirubin of 14. Her platelet count on admission was 111, currently is 93. She has some mild microcytic anemia and no leukopenia and in the differential she has increased monocytosis. Her viral hepatitis serology panel shows hepatitis a IgM that is negative hepatitis B surface antigen and core antibody negative, hepatitis B surface antibody positive consistent with previous vaccination, and hepatitis C antibody negative. COVID-19 antigen was negative on admission 2/10/2021 she reports that she had a Covid PCR done in her office 5 days or so before admission that was also negative. She has been seen by our GI who evaluated her liver abnormalities. Imaging studies including a CT scan of 2/10/2021 showed chronic changes in the colon that could be consistent with inflammatory process such as ulcerative colitis, and a diffuse heterogeneous enhancement of the liver with nodularity that could be consistent with cirrhosis. She has a splenic varices and gastric varices which would make the diagnosis of cirrhosis certainly possible. An MRI of her abdomen on 2/11/2021 shows confirmation of the cirrhotic changes in the liver biliary dilatation or gallbladder abnormalities. There is evidence of portal hypertension. He also had a liver ultrasound that shows findings consistent with possible cirrhosis, including splenomegaly, hepatomegaly, and GB sludge. Alpha 1 antitrypsin, LKM antimitochondrial and anti-smooth muscle antibodies are negative. ANA and ANCA are pending. CMV and EBV PCR are pending. Given the unclear underlying etiology of her liver abnormalities, she had a liver biopsy. Result-Suggestive of NASH and confirms F4 cirrhosis. The patient was a started on Cipro and Flagyl empirically because of the findings on the colon suggestive of possible cholangitis. She has normal renal function. She has had no tick bites, no exposure to animals, no external factors consistent with atopic dermatitis or allergic type of rash. She reports that before admission, she had normal platelets about 1 or 2 years ago when she was tested, as well as normal liver function test. She reports that she has had some mild epistaxis as well as bleeding from her lips. She has some anorexia, she has had some looser stools but has been clear without obvious blood and she has had no hematuria. EGD on 15FEB2021- mild portal hypertensive gastropathy. Low risk esophageal varices. Labwork 15FEB2021- AST 173/ALT 64/Alk Phos 235/Plt 109/ Discharged on 02/15/2021 to home with plans for follow-up with GI and PCP. Prescribed Prednisone with taper off after 28 days. Follow-up appointment has not yet occurred as of the day this report is submitted(2/19/2021).


VAERS ID: 1041355 (history)  
Form: Version 2.0  
Age: 33.0  
Sex: Male  
Location: Oklahoma  
Vaccinated:2021-02-08
Onset:2021-02-18
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH PFIZER / UNK LA / SYR

Administered by: Work       Purchased by: ?
Symptoms: Abdominal pain, Alanine aminotransferase increased, Aspartate aminotransferase increased, Blood lactate dehydrogenase increased, Blood smear test, Chills, Epistaxis, HIV test, Haptoglobin, Hepatitis viral test, Hyperhidrosis, Nausea, Platelet count decreased, Thrombocytopenia, Vomiting
SMQs:, Liver related investigations, signs and symptoms (narrow), Acute pancreatitis (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Norvasc 10mg QD, Coreg 25mg BID, Zoloft 100mg QD, Elavil 100mg QHS
Current Illness: Carbon monoxide poisioning approximately 1 month prior.
Preexisting Conditions: Anxiety, Bipolar, Hypertension, tobacco use
Allergies: Latex
Diagnostic Lab Data: AST: 119, ALT: 55, Platelets 19,000, LDH 2150. Many more labs pending: peripheral smear, haptoglobin, HIV, hepatitis panel,
CDC Split Type:

Write-up: Pt is currently hospitalized under my care with new onset thrombocytopenia, with platelets at 19,000. He has abdominal pain, nausea and vomiting, and diaphoresis with chills. No symptomatic bleeding at this time. Did admit to nose bleed a few days prior to admission.


VAERS ID: 1041487 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2021-02-01
Onset:2021-02-09
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-02-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9261 / 2 RA / IM

Administered by: Work       Purchased by: ?
Symptoms: Acute myocardial infarction, Atrial fibrillation, Dyspnoea, Heart rate irregular, Pulmonary embolism
SMQs:, Anaphylactic reaction (broad), Myocardial infarction (narrow), Supraventricular tachyarrhythmias (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient developed shortness of breath and irregular heart beat 8 days after receiving immunization. Presented to the Clinic and was sent to the Emergency Department for evaluation. Admitted for PE, NSTEMI, and afib with RVR 2/11/21. Discharged to home 2/12/21.


Result pages: prev   20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=29&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19&VAXMAN=PFIZER/BIONTECH


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166